Michael Harrop
Well-known member
https://advanced.onlinelibrary.wiley.com/doi/10.1002/advs.78842
The "n=" is not super clear:
The "n=" is not super clear:
Fecal samples were collected from children (n = 81)
Correlation analysis across 37 patients
ABSTRACT
Autism spectrum disorder (ASD) is increasingly linked to gut microbial dysbiosis, yet fecal microbiota may not adequately reflect host–microbe interactions at the intestinal mucosa. This study compares colonic in situ and fecal microbiota in children with ASD, evaluates their associations with clinical severity, and examines their responses to washed microbiota transplantation (WMT).
Colonic in situ microbiota show marked structural and compositional divergence from fecal microbiota, with limited overlap between compartments. Despite lower microbial diversity, colonic microbiota exhibit broader and stronger associations with ASD severity, including Autism Behavior Checklist (ABC) and Childhood Autism Rating Scale (CARS) scores.
In germ-free ASD model mice, transplantation of healthy donor microbiota alleviates autism-like behaviors. Consistently, WMT improves clinical symptoms in children with ASD and progressively shifts colonic microbiota toward donor-like configurations. Colonic microbiota changes are associated with symptom improvement, and exploratory predictive analyses suggest that integrating colonic in situ microbiota with clinical features may provide additional predictive information compared with fecal microbiota-based models.
These findings suggest that clinically sampled colonic in situ microbiota may provide complementary information for understanding ASD heterogeneity and treatment response, although further validation is warranted.
Colonoscopy was not performed solely for research purposes. All children undergoing colonoscopy were clinically scheduled to receive WMT, and colonoscopy was required for transendoscopic enteral tube placement as part of the established WMT procedure. No colonic mucosal biopsy was performed for microbiota collection.
Fecal samples were collected from children (n = 81) before the intestinal preparation required for colonoscopy.
Colonic in situ microbiota were collected through the placed enteral tube by gentle saline infusion and aspiration, without additional tissue injury.
Colonic in situ microbiota suspensions were obtained from children with ASD (n = 48) with the patients positioned in the right lateral decubitus position. Following transendoscopic placement of an enteral tube, the first in situ sample was collected within 1 h. Using a sterile syringe, 30 mL of normal saline was gently infused into the ascending colon through the tube. After allowing the saline to equilibrate for 2 min, the colonic in situ microbiota suspension was aspirated and centrifuged at 3000 rpm for 5 min.
Healthy donors were screened through a combination of questionnaires, physical examinations, blood tests, and stool analyses [11]. A total of 25 individuals unrelated to the recipients were enrolled as healthy donors, including 11 males and 14 females, with a median age of 25.0 years (interquartile range, 23.0–26.5 years) and a mean body mass index (BMI) of 20.1 ± 2.1 kg/m2. All donors were younger than 30 years and had a BMI below 24 kg/m2. Eligible donors were required to have regular lifestyles, healthy dietary habits, normal bowel movements, no history of chronic or infectious diseases, and no recent antibiotic use.
- Format correct?
- Yes